Analyze Diet
Talanta2009; 80(2); 954-958; doi: 10.1016/j.talanta.2009.08.019

Antibodies conjugated with new highly luminescent Eu3+ and Tb3+ chelates as markers for time resolved immunoassays. Application to simultaneous determination of clenbuterol and free cortisol in horse urine.

Abstract: Highly luminescent Eu(3+) and Tb(3+) complexes of 10-[4-(3-isothiocyanatopropoxy)benzoylmethyl]-1,4,7,10-tetraazacyclododecane-1,4,7 triacetic acid Eu(3+) is a subset of 1 and Tb(3+) is a subset of 1 were conjugated with a goat anti-rabbit IgG and a rabbit anti-mouse IgG, respectively, and applied as markers in a time resolved immunoassay for simultaneous quantitative determination of anabolic compounds clenbuterol (CL) and hydrocortisone (HC). The assay was performed in horse urine, using a monoclonal antibody specific to CL and a rabbit polyclonal antibody specific to the free HC. These lanthanide chelates are very stable and highly luminescent in aqueous solution and allowed to reach 10 microg L(-1) and 40 microg L(-1) sensitivities for CL and for HC, respectively. Application to the horse urine, that is a very complex matrix, has a considerable interest in the control of illegal use of these compounds.
Publication Date: 2009-08-22 PubMed ID: 19836578DOI: 10.1016/j.talanta.2009.08.019Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research examines the use of luminescent compounds, specifically Eu(3+) and Tb(3+) complexes, conjugated with antibodies for quantitative determination of clenbuterol and hydrocortisone in horse urine. The study demonstrates high sensitivity and has significant implications for controlling illicit drug use in horses.

Research Methodology and Resources

  • The experiment hinged around the use of luminescent Eu(3+) and Tb(3+) complexes which were linked, or conjugated, with specific antibodies – specifically, a goat anti-rabbit IgG and a rabbit anti-mouse IgG.
  • Theses specific antibodies were then used in a time resolved immunoassay, a biochemical test that measures the presence or concentration of a macromolecule in solutions through the use of an immune reaction.
  • This assay was specifically used for the simultaneous quantitative determination of clenbuterol (CL) and hydrocortisone (HC), two substances sometimes improperly used in horse racing to increase performance.

Key Findings

  • The research found that these lanthanide chelates (compounds containing a metal ion attached to a certain molecule, in this case the Eu(3+) and Tb(3+) complexes) were both stable and highly luminescent in aqueous solution.
  • This luminescence allowed for the detection of clenbuterol and hydrocortisone in horse urine samples at sensitivities of 10 microg L(-1) and 40 microg L(-1), respectively.
  • Given the sensitivity of these compounds and their ability to function in a complex matrix like horse urine, this method offers potential for controlling the improper use of these substances in horses.

Implications and Association

  • Clenbuterol and hydrocortisone are both substances that can be used to illicitly improve horse performance in racing, leading to unfair competition and potential harm to the horses.
  • Therefore, the development of sensitive and accurate detection methods is paramount in controlling this abuse.
  • This study shows the potential use of luminescent conjugated antibodies in developing such detection methods, contributing to efforts to maintain ethical and safe practices in the horse racing industry.

Cite This Article

APA
Bacigalupo MA, Meroni G, Secundo F, Scalera C, Quici S. (2009). Antibodies conjugated with new highly luminescent Eu3+ and Tb3+ chelates as markers for time resolved immunoassays. Application to simultaneous determination of clenbuterol and free cortisol in horse urine. Talanta, 80(2), 954-958. https://doi.org/10.1016/j.talanta.2009.08.019

Publication

ISSN: 1873-3573
NlmUniqueID: 2984816R
Country: Netherlands
Language: English
Volume: 80
Issue: 2
Pages: 954-958

Researcher Affiliations

Bacigalupo, M A
  • Istituto di Chimica del Riconoscimento Molecolare, CNR, Milan, Italy. mariangela.bacigalupo@icrm.cnr.it
Meroni, G
    Secundo, F
      Scalera, C
        Quici, S

          MeSH Terms

          • Animals
          • Antibodies, Monoclonal / chemistry
          • Antibodies, Monoclonal / immunology
          • Biomarkers / chemistry
          • Chelating Agents / chemistry
          • Clenbuterol / chemistry
          • Clenbuterol / urine
          • Doping in Sports / prevention & control
          • Europium / chemistry
          • Horses
          • Hydrocortisone / chemistry
          • Hydrocortisone / urine
          • Immunoassay / instrumentation
          • Immunoassay / methods
          • Immunoglobulin G / immunology
          • Luminescence
          • Luminescent Measurements
          • Molecular Structure
          • Reproducibility of Results
          • Terbium / chemistry

          Citations

          This article has been cited 3 times.
          1. Xiao S, Sun L, Kang M, Dong Z. A label-free aptasensor for clenbuterol detection based on fluorescence resonance energy transfer between graphene oxide and rhodamine B. RSC Adv 2022 Nov 9;12(50):32737-32743.
            doi: 10.1039/d2ra06260gpubmed: 36425698google scholar: lookup
          2. Liu J, Liu ZB, Huang Q, Lin CQ, Lin X. Highly sensitive fluorescent probe for clenbuterol hydrochloride detection based on its catalytic oxidation of eosine Y by NaIO4. J Fluoresc 2014 Sep;24(5):1495-501.
            doi: 10.1007/s10895-014-1435-7pubmed: 25155629google scholar: lookup
          3. Hagan AK, Zuchner T. Lanthanide-based time-resolved luminescence immunoassays. Anal Bioanal Chem 2011 Jul;400(9):2847-64.
            doi: 10.1007/s00216-011-5047-7pubmed: 21556751google scholar: lookup